iSpecimen Inc. (ISPC) vs Onconetix, Inc. (ONCO)
A side-by-side comparison of iSpecimen Inc. and Onconetix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ISPC
iSpecimen Inc.
$1.06HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
ONCO
Onconetix, Inc.
$0.66HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — ISPC vs ONCO
growth of $100 · dividends reinvested · last 5yISPC -100.0% (-80.2%/yr)ONCO -100.0% (-96.3%/yr)ISPC compounded faster over this window
Log scale — wide-divergence pair
ISPC ONCO
ISPC vs ONCO: by the numbers
- •ISPC is the larger company ($3M vs $2M market cap).
- •Both run net losses; ONCO's is the smaller (-1578.79% vs -2449.04% net margin).
Metrics side by side
Valuation
| Metric | ISPC | ONCO |
|---|---|---|
| P/S ratio | 5.72 | 3.68 |
| P/B ratio | 1.54 | 0.18 |
Profitability
| Metric | ISPC | ONCO |
|---|---|---|
| Gross margin | 1.25% | 80.40% |
| Operating margin | -465.42% | -778.16% |
| Net margin | -2449.04% | -1578.79% |
| ROE | -657.69% | -75.70% |
| ROIC | -476.39% | -59.84% |
Growth (annualized)
| Metric | ISPC | ONCO |
|---|---|---|
| Revenue CAGR (5Y) | -46.70% | N/A |
| Total return CAGR (5Y) | -81.14% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.